Results 191 to 200 of about 23,127 (334)

Incretins: Beyond type 2 diabetes

Diabetes, obesity and metabolism, 2018
P. Dandona, H. Ghanim, A. Chaudhuri
semanticscholar   +1 more source

Dairy Intake and Type 2 Diabetes Mellitus in Iranian Older Adults: Insights From the Baseline Phase of the Birjand Longitudinal Aging Study

Endocrinology, Diabetes &Metabolism, Volume 9, Issue 3, May 2026.
Among 1348 Iranian adults aged ≥ 60 years in the BLAS baseline, total dairy intake showed no clear association with prevalent T2DM (adjusted OR: 1.42, p = 0.05). Higher yogurt (OR: 1.48–1.54) and cheese (OR: 1.44) intakes were linked to greater odds, whereas milk was not.
Mahboubeh Darabi, Amirmohammad Tajik, Mehraneh Movahedi Aliabadi, Zeinab Shakeri, Maryam Mohammadi, Hossein Fakhrzadeh, Mitra Moudi, Masoumeh Khorashadizadeh, Mehdi Varmaghani, Farshad Sharifi   +9 more
wiley   +1 more source

Bariatric surgery and obesity: influence on the incretins.

International Journal of Obesity Supplements, 2016
B. Laferrère
semanticscholar   +1 more source

Comparative Efficacy and Safety of Ecnoglutide in Type 2 Diabetes: A Systematic Review and Meta‐Analysis

Endocrinology, Diabetes &Metabolism, Volume 9, Issue 3, May 2026.
Ecnoglutide, a once‐weekly GLP‐1 receptor agonist, significantly improves glycaemic control and promotes meaningful weight loss compared with placebo in type 2 diabetes. This systematic review and meta‐analysis of four RCTs demonstrates favourable efficacy with mostly mild gastrointestinal adverse events and no increase in serious safety concerns ...
Mukesh Kumar, Sumet Kumar, Sheikh Muhammad Ebtehaj Ali, Hadia Qazi, Arshia Arif Janjua, Hanzlah Ahmed, Rayan Babar, Rumaisa Imtiaz Sheikh, Laksh Kumar, Sana Mohammad Ali, Fatima Hanif, Khizra Gul, Ayesha Sarwar Ali, Shehzadi Umme Rubab Bukhari, Adarsh Raja, Aayush Chaulagain   +15 more
wiley   +1 more source

Endogenous GIP signaling is indispensable for DPP-4 inhibitor-mediated metabolic control in mice. [PDF]

J Diabetes Investig
Kubota-Okamoto S, Kubota S, Tsuchida H, Liu Y, Banno S, Imaizumi T, Fujisawa T, Takahashi Y, Kato T, Horikawa Y, Iizuka K, Murakami T, Fujiwara Y, Kuwata H, Yamazaki Y, Seino Y, Tsunekawa S, Yabe D.   +17 more
europepmc   +1 more source

The Efficacy of Imeglimin and Metformin on Insulin Sensitivity and Secretion Using Oral Minimal Model: Sub‐Analysis of an Exploratory Randomised Controlled Trial

Diabetes, Obesity and Metabolism, Volume 28, Issue 6, Page 5384-5388, June 2026.
Ryota Usui, Yoshiyuki Hamamoto, Yasuhiro Omori, Hisato Tatsuoka, Takashi Hayakawa, Kazuhiro Shimomura, Kenta Murotani, Hitoshi Kuwata, Yuichiro Yamada, Yutaka Seino   +9 more
wiley   +1 more source

Correction: Regulation of glucose metabolism by incretins: implications for treatment of type 2 diabetes. [PDF]

Diabetol Int
Saito R, Harada N.
europepmc   +1 more source

Incretins amplify TNF-α-stimulated IL-6 synthesis in osteoblasts: Suppression of the IκB/NF-κB pathway.

International Journal of Molecular Medicine, 2017
Kazuhiko Fujita, H. Tokuda, Naohiro Yamamoto, Shingo Kainuma, Tetsu Kawabata, Go Sakai, Gen Kuroyanagi, R. Matsushima-Nishiwaki, A. Harada, O. Kozawa, T. Otsuka   +10 more
semanticscholar   +1 more source

Tirzepatide as Adjunct to Insulin in Adults With Type 1 Diabetes and Overweight or Obesity: A Systematic Review of Randomized and Real‐World Evidence

Endocrinology, Diabetes &Metabolism, Volume 9, Issue 3, May 2026.
Tirzepatide as adjunct to insulin in adults with type 1 diabetes and overweight or obesity shows the most consistent signal for body weight reduction, with possible improvements in HbA1c and insulin requirements. However, current evidence remains early, low‐certainty, and insufficient to establish long‐term efficacy or safety.
Giuseppina Alessia Acucella, Danilo Caponio   +1 more
wiley   +1 more source

Antiobesity Medications for Older Adults-the New, the Good, the Bad, and the Unknown. [PDF]

Obesity (Silver Spring)
Pendrey A, Sevilla-Martir J.
europepmc   +1 more source